Microchip Technology Incorporated (MCHP) — 2024Q1 FY2024 Earnings Call Analysis

167 Days of Inventory vs. The 40% Floor

Lead times collapsed from 52 weeks to 26 weeks in 90 days, yet management claims pricing power is untouched.

Thesis: MCHP is attempting a high-wire act: managing a severe cyclical correction while promising structural margin resilience. The collapse in lead times (targeting <13 weeks) destroys the 'Backlog Fortress' thesis—customers stop ordering when they know they can get parts instantly. They are running internal fabs full ('relatively unchanged') to mask gross margin compression, bloating inventory to 167 days. The 'soft landing' guidance contradicts the 'amplified' weakness acknowledged for December.

Verdict: SHORT — Conviction: MEDIUM

Catalyst: December quarter guidance. Management admitted it will be 'seasonally weaker than normal' and 'amplified' by macro weakness.

Key Risk: The 'Margin Expansion Engine' holds. If they maintain >40% operating margins through the trough, the valuation re-rates higher on proven resilience.

The Tell: The CFO admitted December seasonality would be 'amplified by the macro weakness' immediately after guiding the current quarter flat. They are kicking the can exactly one quarter down the road.

Detected Patterns

Friction Level: HIGH_FRICTION — Bulls buy the '40% operating margin floor' promise; Bears see an air pocket forming as 52-week phantom backlog evaporates into true demand.

Report not found

The report data is no longer available. Please return to the archive.